This alliance will drive research in pediatric cancer epigenetics, through access to IRB Barcelona's top-notch infrastructure, with the ultimate goal of translating this innovative knowledge into tang...
Read moreA research team from IRB Barcelona and the biotech Nostrum Biodiscovery has developed a new type of inhibitor that blocks only some of the functions of the p38 protein. The alternative pathway that th...
Read moreLiderado por la Dra. Stefanie Wculek, el nuevo grupo de investigación se centrará en el estudio del sistema inmune y su función en los tejidos, tanto en la salud como en la respuesta a la enfermeda...
Read moreThe 7 IRB Barcelona projects that have been awarded funding seek to advance research into cancer, with a focus on the cancer patient and increasing survival rates.
Read moreResearchers at CNIO and IRB Barcelona reveal the function of HAT proteins, which serve as gates for the cellular entry and exit of amino acids.
Read moreNuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its w...
Read moreResearchers from the Microtubule Organization lab, headed by Jens Lüders at IRB Barcelona, and the Macromolecular Complexes in DNA Damage Response Group, led by Oscar Llorca at the Spanish National C...
Read moreEl Institut de Recerca Sant Joan de Déu y el Institut de Recerca Biomèdica firman un acuerdo de colaboración para promover acciones conjuntan con el grupo de jóvenes KIDS Barcelona y Crazy About B...
Read moreScientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group...
Read moreResearchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel te...
Read moreProyectos en salud impulsados por el IRB Barcelona, el CRG, el IBEC y la UAB obtienen las prestigiosas becas del Consejo Europeo de Investigación
Read moreIn a study published in Cell Reports,the scientists inhibited the capacity of RAS to block cell death, thus eliminating malignant tumours without affecting the development of organs. The results of th...
Read more